ScholarIQanswers from OpenAlex

MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma

PaperCitations, authors & open-access status

MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma have?

ScholarIQcitation count

MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma has 64 citations in the OpenAlex counts ScholarIQ stores.

When was MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma published?

ScholarIQyear

MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma has 2018 year in the ScholarIQ index.

What is the open-access status of MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma?

ScholarIQoa status

MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma has gold oa status in the ScholarIQ index.

What is the DOI of MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma?

ScholarIQdoi

The DOI for MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma is on the source record.

What is the PMID of MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma?

ScholarIQpmid

The PMID for MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma is on the source record.

What is the OpenAlex record for MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma?

ScholarIQopenalex

The OpenAlex for MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial